iKang Healthcare Group (NASDAQ: KANG) is one of 45 publicly-traded companies in the “Healthcare Facilities & Services” industry, but how does it contrast to its competitors? We will compare iKang Healthcare Group to related companies based on the strength of its risk, institutional ownership, valuation, dividends, analyst recommendations, earnings and profitability.
This table compares iKang Healthcare Group and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|iKang Healthcare Group||0.79%||1.30%||0.60%|
|iKang Healthcare Group Competitors||13.21%||0.86%||1.95%|
33.5% of iKang Healthcare Group shares are owned by institutional investors. Comparatively, 75.4% of shares of all “Healthcare Facilities & Services” companies are owned by institutional investors. 13.0% of shares of all “Healthcare Facilities & Services” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Valuation & Earnings
This table compares iKang Healthcare Group and its competitors gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|iKang Healthcare Group||$435.71 million||-$11.25 million||470.50|
|iKang Healthcare Group Competitors||$6.36 billion||$163.89 million||231.52|
iKang Healthcare Group’s competitors have higher revenue and earnings than iKang Healthcare Group. iKang Healthcare Group is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.
This is a breakdown of recent recommendations and price targets for iKang Healthcare Group and its competitors, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|iKang Healthcare Group||0||0||0||0||N/A|
|iKang Healthcare Group Competitors||257||1521||2033||39||2.48|
As a group, “Healthcare Facilities & Services” companies have a potential upside of 0.58%. Given iKang Healthcare Group’s competitors higher probable upside, analysts clearly believe iKang Healthcare Group has less favorable growth aspects than its competitors.
Risk and Volatility
iKang Healthcare Group has a beta of 0.26, meaning that its stock price is 74% less volatile than the S&P 500. Comparatively, iKang Healthcare Group’s competitors have a beta of 0.67, meaning that their average stock price is 33% less volatile than the S&P 500.
iKang Healthcare Group competitors beat iKang Healthcare Group on 8 of the 10 factors compared.
iKang Healthcare Group Company Profile
iKang Healthcare Group, Inc. provides preventive healthcare solutions, including a range of medical examinations services and value-added services, including disease screening, dental services and other services in China. The Company’s segments include medical examinations and other medical services, and dental services. The Company, through its integrated service platform, offers healthcare management solutions, including medical examinations, which cover basic examination items, such as internal, gynecology, ophthalmology, dental and X-ray, and value-added services at selected medical centers, including disease screening focusing on cancer screening, cardiovascular disease screening, certain chronic disease screening and functional medicine testing; dental care, including oral health, pediatric dentistry and cosmetic dentistry; outpatient services, such as acupuncture, obstetrics, gynecology and minor surgery, and on-site healthcare management or clinics at certain locations.
Receive News & Ratings for iKang Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iKang Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.